💊 A once-daily trientine formulation is entering phase 3 testing as a potential first-line treatment for #WilsonDisease

🧬 The trial will compare trientine with D-penicillamine, assessing efficacy, safety, and tolerability

🔎 Read 👉 www.neurologylive.com/view/once-da...
#Neurology #ClinicalTrials